MC
TMO icon

Maverick Capital’s Thermo Fisher Scientific TMO Stock Holding History

Maverick Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-749
Closed -$435K – 461
2024
Q1 		$435K Sell
749
-772
-51% -$433K 0.01% 254
2023
Q4 		$807K Buy
1,521
+738
+94% +$357K 0.02% 146
2023
Q3 		$396K Buy
+783
New +$417K 0.01% 194
2021
Q3 		– Sell
-876
Closed -$442K – 796
2021
Q2 		$442K Sell
876
-1,519
-63% -$717K ﹤0.01% 398
2021
Q1 		$1.09M Buy
2,395
+1,297
+118% +$619K 0.01% 236
2020
Q4 		$511K Buy
+1,098
New +$515K 0.01% 355
2020
Q2 		– Sell
-221
Closed -$63K – 666
2020
Q1 		$63K Buy
+221
New +$69.7K ﹤0.01% 446
2019
Q4 		– Sell
-12,086
Closed -$3.52M – 421
2019
Q3 		$3.52M Buy
+12,086
New +$3.46M 0.05% 214
2019
Q2 		– Sell
-26,370
Closed -$7.22M – 345
2019
Q1 		$7.22M Buy
26,370
+4,350
+20% +$1.08M 0.1% 117
2018
Q4 		$4.93M Buy
22,020
+10,690
+94% +$2.51M 0.07% 184
2018
Q3 		$2.77M Buy
+11,330
New +$2.61M 0.03% 203

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Maverick Capital's TMO Position: Q2 2024 in Review

Maverick Capital sold out of Thermo Fisher Scientific (TMO) in Q2 2024, closing a stake of 749 shares — an estimated $435K sold.

Maverick Capital first reported a position in TMO in Q3 2018 and held it in 11 quarters. The position peaked at $7.22M in Q1 2019. 2,542 funds tracked by Wall St. Rank hold TMO as of Q2 2024.

  • Maverick Capital reported no remaining Thermo Fisher Scientific position as of Q2 2024 after selling out during the quarter.
  • Maverick Capital sold 749 Thermo Fisher Scientific shares in Q2 2024, an estimated $435K.
  • Maverick Capital first reported a position in Thermo Fisher Scientific in Q3 2018 and held it in 11 quarters.
  • Maverick Capital's Thermo Fisher Scientific position peaked at $7.22M in Q1 2019.
  • 2,542 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2024.

Based on Maverick Capital's 13F filing for Q2 2024, filed 14 Aug 2024.